Decibel Therapeutics DBTX stock price is finally showing some life as it reverses trend. DBTX is up 59% in the last 5 days and I will be evaluating many factors to determine just how hot the stock is.
The official heat level for SMCE is, a 🔥🔥 2 out of 5.
Continue reading to see why I think it is just a 2 out of 5. There is some shocking takeaways from this article that you must read if you are interested in DBTX.
If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.
Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.
I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.
What do I mean by big winners?
Stocks that move more than 100% in a month! DBTX Stock Price could?
Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!
The article is HERE and I shine a spotlight on these breakout stocks and also those losers!
Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.
Decibel Therapeutics Company Information
Company Name: Decibel Therapeutics Inc.
Breakout Stock Decibel Therapeutics Company Summary:
Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss, residual hearing preservation or improved sound fidelity with cochlear implants, presbycusis or age-related hearing loss, tinnitus, a persistent ringing in the ears, and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded by Kevin Paul Starr, M. Charles Liberman, Gabriel Corfas, Ulrich Müller, and Albert Edge in October 2015 and is headquartered in Boston, MA.
DBTX stock price is due to News?
June 28, 2022
Today reported positive top-line results from an interim analysis of its ongoing Phase 1b clinical trial of DB-020, a novel, proprietary formulation of sodium thiosulfate (STS) designed to protect against hearing loss in cancer patients receiving cisplatin chemotherapy. Cisplatin, one of the most commonly used chemotherapeutic agents, has severe dose-limiting side effects, including ototoxicity, which leads to permanent hearing loss in many patients. There are no approved therapies to prevent or treat cisplatin-induced ototoxicity.
Trending Stock DBTX 5 Day Chart
DBTX Stock Price HOT Stock Grade:
The official heat level for DBTX is, a 🔥🔥 2 out of 5 . Continue reading to see why I think it is just a 2 out of 5. Here are my takeaways on DBTX and why it is just a 2 out of 5.
The volume, which is basically demand of a stock is sporadic and has a downward pressure on it.
The news, there is no significant news cycle circulating around DBTX stock price.
The chart, it is bearish and has been that way for a while.
The fundamentals, there is no exciting financial filings associated with this stock.
Marketing efforts, I have found marketing efforts around the investor awareness of this company which saved it from a 1 out of 5 rating.
To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇